<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38102626</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1745-6673</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of occupational medicine and toxicology (London, England)</Title><ISOAbbreviation>J Occup Med Toxicol</ISOAbbreviation></Journal><ArticleTitle>Pulmonary function assessment after COVID-19 in vaccinated healthcare workers.</ArticleTitle><Pagination><StartPage>31</StartPage><MedlinePgn>31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">31</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12995-023-00400-7</ELocationID><Abstract><AbstractText>COVID-19 typically presents with flu-like symptoms due to the viral infection itself. The most severe cases are characterised by lung damage, an important factor in fatal outcome due to alveolar damage. In some cases, patients develop a long COVID with persistent symptoms of chest pain and fatigue. Causes, including organ damage or inflammation, are being investigated. Clinical outcomes are variable and permanent lung damage is not fully understood, while vaccination is effective against severe infection but its effect on respiratory function in mild cases remains uncertain. This retrospective study aims to analyse changes in lung function in HCWs who had COVID-19 between 2020 and 2022, comparing their spirometric test results before and after the pandemic and taking into account their vaccination status. 321 HCWs were included in the study. The study examined spirometric parameters both before and after the pandemic, and all measured outcomes except the FEV1/FVC ratio showed a significant decrease during the study period. We then assessed the association between SARS-CoV-2 infection and changes in lung function parameters, analysing infections in 2020, 2021 and 2022 separately. We found a statistically significant difference in Forced vital capacity (FVC) between infected and non-infected subjects in 2020 and 2021, but not in 2022. To evaluate the protective effect of SARS-CoV-2 vaccination on respiratory function, a linear regression analysis was performed using changes in FVC, Forced expiratory volume in 1&#xa0;s (FEV1), FVC/FEV1 ratio and Peak expiratory flow (PEF) as dependent variables. The analysis showed that the decline in FVC was significantly lower in subjects who had been vaccinated prior to infection. The study concludes that subclinical SARS-CoV-2 infections in 2020 and 2021 worsened respiratory parameters (FVC and FEV1), but vaccination protected against these effects. Even healthy individuals with previous infections showed respiratory changes, with vaccination providing protection, especially for FVC decline. This highlights the importance of vaccinating healthcare workers against COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ippoliti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy. ippoliti.lo@libero.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppeta</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somma</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bizzarro</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crispino</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannuzzi</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazza</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paolino</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietroiusti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Saint Camillus International University of Health Sciences, Rome, 00131, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Occup Med Toxicol</MedlineTA><NlmUniqueID>101245790</NlmUniqueID><ISSNLinking>1745-6673</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Healthcare workers</Keyword><Keyword MajorTopicYN="N">Respiratory function</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Spirometry</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>16</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>16</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38102626</ArticleId><ArticleId IdType="pmc">PMC10724929</ArticleId><ArticleId IdType="doi">10.1186/s12995-023-00400-7</ArticleId><ArticleId IdType="pii">10.1186/s12995-023-00400-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M, Werlein C, L&#xe4;nger F, K&#xfc;hnel MP, Jonigk DD. COVID-19: Auswirkungen Auf Lunge Und Herz [COVID-19: effects on the lungs and heart] Pathologe. 2021;42(2):164&#x2013;71. doi: 10.1007/s00292-021-00918-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00292-021-00918-9</ArticleId><ArticleId IdType="pmc">PMC7871953</ArticleId><ArticleId IdType="pubmed">33560456</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Calabrese F, Sbaraglia M, Del Vecchio C, Carretta G, Saieva A, Donato D, Flor L, Crisanti A, Dei Tos AP. Feasibility of postmortem examination in the era of COVID-19 pandemic: the experience of a Northeast Italy University Hospital. Virchows Arch. 2020;477:341&#x2013;7. doi: 10.1007/s00428-020-02861-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02861-1</ArticleId><ArticleId IdType="pmc">PMC7282199</ArticleId><ArticleId IdType="pubmed">32519035</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;sm&#xfc;ller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch. 2021;478(1):137&#x2013;50. doi: 10.1007/s00428-021-03053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-021-03053-1</ArticleId><ArticleId IdType="pmc">PMC7892326</ArticleId><ArticleId IdType="pubmed">33604758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, Vander K, Bargfrieder U, Trauner M. Pulmonary arterial Thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173:350&#x2013;61. doi: 10.7326/M20-2566.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2566</ArticleId><ArticleId IdType="pmc">PMC7249507</ArticleId><ArticleId IdType="pubmed">32422076</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. 2021. CT of Post-Acute Lung Complications of COVID-19. Epub 2021 Aug 10. PMID: 34374591; PMCID: PMC8369881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211396</ArticleId><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, Vilar&#xf3; J. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonol 2021 Jul-Aug;27(4):328&#x2013;37. 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Cheng Koc,Jing Xiao, Liu W, Li Y. Guokai Chen Long COVID and its management published online 2022 Jul 11. 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brian L, Graham I, Steenbruggen et al. Standardization of Spirometry 2019 Update. An official American Thoracic Society and European Respiratory Society Technical Statement American Journal of respiratory and critical Care Medicine Volume 200 Number 8 | October 15 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, Ryerson CJ, Guenette JA. Pulmonary function and functional capacity in COVID-19 survivors with persistent Dyspnoea. Respir Physiol Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, Th&#xe5;lin C. Symptoms and functional impairment assessed 8 months after mild COVID-19 among Health Care workers. JAMA. 2021;325(19):2015&#x2013;6. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xianming Zhu, Kelly A, Gebo, Alison G, Abraham F, Habtehyimer, Eshan U, Patel O, Laeyendecker et al. Dynamics of inflammatory responses after SARS-CoV-2 Infection by vaccination status in the USA: a prospective cohort study the Lancet microbe August 07, 2023 DOI:10.1016/S2666-5247(23)00171-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10475695</ArticleId><ArticleId IdType="pubmed">37659419</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>